Trevi Therapeutics, Inc. · NASDAQ:TRVI

Rubric Capital Management LP's stake in Trevi Therapeutics, Inc. fell to 2.94% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 13, 2026

Rubric Capital Management LP's stake in Trevi Therapeutics, Inc. fell to 2.94%, 3,766,749 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).

Stake
2.94%
Shares
3,766,749
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Rubric Capital Management LP2.94%3,766,749
David Rosen2.94%3,766,749

Source

View original at SEC

Related